90 related articles for article (PubMed ID: 17725098)
21. The porphyrias: pathophysiology.
Pietrangelo A
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S65-71. PubMed ID: 20865477
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
23. In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastoma.
Aerts I; Leuraud P; Blais J; Pouliquen AL; Maillard P; Houdayer C; Couturier J; Sastre-Garau X; Grierson D; Doz F; Poupon MF
Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):275-83. PubMed ID: 21112551
[TBL] [Abstract][Full Text] [Related]
24. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
25. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
26. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
27. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.
Reinhard J; Wagner N; Krämer MM; Jarocki M; Joachim SC; Dick HB; Faissner A; Kakkassery V
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560557
[TBL] [Abstract][Full Text] [Related]
28. siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines.
Miyake M; Ishii M; Kawashima K; Kodama T; Sugano K; Fujimoto K; Hirao Y
Photochem Photobiol; 2009; 85(4):1020-7. PubMed ID: 19320847
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate enhances 5-aminolevulinic acid-mediated photodynamic therapy-induced killing of human SCC4 cells by upregulation of coproporphyrinogen oxidase.
Yang DF; Lee JW; Chen HM; Huang Z; Hsu YC
J Formos Med Assoc; 2014 Feb; 113(2):88-93. PubMed ID: 24485831
[TBL] [Abstract][Full Text] [Related]
30. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
Brodowska K; Al-Moujahed A; Marmalidou A; Meyer Zu Horste M; Cichy J; Miller JW; Gragoudas E; Vavvas DG
Exp Eye Res; 2014 Jul; 124():67-73. PubMed ID: 24837142
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
[TBL] [Abstract][Full Text] [Related]
32. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.
Ishizuka M; Abe F; Sano Y; Takahashi K; Inoue K; Nakajima M; Kohda T; Komatsu N; Ogura S; Tanaka T
Int Immunopharmacol; 2011 Mar; 11(3):358-65. PubMed ID: 21144919
[TBL] [Abstract][Full Text] [Related]
33. Impact of thiosemicarbazones on the accumulation of PpIX and the expression of the associated genes.
Gawecki R; Malarz K; Rejmund M; Polanski J; Mrozek-Wilczkiewicz A
J Photochem Photobiol B; 2019 Oct; 199():111585. PubMed ID: 31450131
[TBL] [Abstract][Full Text] [Related]
34. Accumulation of protoporphyrin-IX in rat Leydig cells following induction by 5-aminolevulinic acid and tramadol.
Wołuń-Cholewa M; Butowska W; Warchoł W
Photomed Laser Surg; 2007 Dec; 25(6):526-9. PubMed ID: 18158756
[TBL] [Abstract][Full Text] [Related]
35. DNA Duplex-Based Photodynamic Molecular Beacon for Targeted Killing of Retinoblastoma Cell.
Wei Y; Lu C; Chen Q; Xing D
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6011-6019. PubMed ID: 27820632
[TBL] [Abstract][Full Text] [Related]
36. Erlotinib has tumor inhibitory effect in human retinoblastoma cells.
Shao Y; Yu Y; Zong R; Quyang L; He H; Zhou Q; Pei C
Biomed Pharmacother; 2017 Jan; 85():479-485. PubMed ID: 27899256
[TBL] [Abstract][Full Text] [Related]
37. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
38. Analyzing effects of photodynamic therapy with 5-aminolevulinic acid (ALA) induced protoporphyrin IX (PPIX) in urothelial cells using reverse phase protein arrays.
Krieg RC; Herr A; Raupach K; Ren Q; Schwamborn K; Knuechel R
Photochem Photobiol Sci; 2007 Dec; 6(12):1296-305. PubMed ID: 18046485
[TBL] [Abstract][Full Text] [Related]
39. Optimization of the heme biosynthesis pathway for the production of 5-aminolevulinic acid in Escherichia coli.
Zhang J; Kang Z; Chen J; Du G
Sci Rep; 2015 Feb; 5():8584. PubMed ID: 25716896
[TBL] [Abstract][Full Text] [Related]
40. Cytokine induced apoptosis in human retinoblastoma cells.
Cullinan AE; Brandt CR
Mol Vis; 2004 Apr; 10():315-22. PubMed ID: 15133451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
